MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0010265
Relixir Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹41.19 Cr
▲ 48% YoY
Net loss · FY 2023
₹5.79 Cr
Net margin -14%
EBITDA · FY 2023
₹28.48 Lakh
EBITDA margin 0.7%
Authorised capital
₹10.5 Cr
Registered with MCA
Paid-up capital
₹10.5 Cr
Issued & subscribed
Satisfied charges
₹26.81 Cr
No open charges
Company age
15 yrs
Est. 2011
Employees · EPFO
60
Provident fund records
About Relixir Pharmaceuticals Private Limited
Data last updated:
Relixir Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2011PTC072584. Its GSTIN is 36AAGCR3136H1ZF (Telangana).
The company has an authorised share capital of ₹10.5 Cr and a paid-up capital of ₹10.5 Cr. It is led by directors Anil Kumar Devanapalli Ramaya and Vinutha Mandula.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at P.No. 24 1 – 89/A/8/1/24 Trendz Jr 4B Gaffor Nagar Madhapur, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2023, the company reported a revenue of ₹41.19 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net loss of ₹5.79 Cr (net margin -14%) and EBITDA of ₹28.48 Lakh (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years.
The company has about 60 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹26.81 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Relixir Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0010265). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website relixirpharma.com.
Company details
CIN U24100TG2011PTC072584
Registration Number 072584
Incorporation Date 14 February 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0010265
CIN history
Relixir Pharmaceuticals has one previous CIN (Corporate Identification Number): U24100AP2011PTC072584. The current CIN is U24100TG2011PTC072584, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2011PTC072584 | Current |
| U24100AP2011PTC072584 | Previous |
Recognitions & Rankings of Relixir Pharmaceuticals
Contact details
Relixir Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is relixirpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressP.No. 24 1 – 89/A/8/1/24 Trendz Jr 4B Gaffor Nagar Madhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Relixir Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Relixir Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Relixir Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Relixir Pharmaceuticals Private Limited, buy the company report.
Financials of Relixir Pharmaceuticals Private Limited
FY 2023 filings availableRelixir Pharmaceuticals Private Limited reported revenue of ₹41.19 Cr (up 48% YoY) for FY 2023.
Revenue · FY 2023
₹41.19 Cr ▲ 48%
Net loss · FY 2023
₹5.79 Cr margin -14%
EBITDA · FY 2023
₹28.48 Lakh margin 0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 48%
3 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▼ 94%
3 years · compounded
▼ 60%
Revenue has grown at a compounded annual rate (CAGR) of 18% over three years, including 48% growth in the latest year. EBITDA fell 94% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.48 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.79 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | -14% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Relixir Pharmaceuticals Private Limited, buy the company report.
Board of directors of Relixir Pharmaceuticals Private Limited
Relixir Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Devanapalli Ramaya Also directs: Sarama Trading LLP, Netpixel Software Solutions India Private Limited, Bharat Jagruthi Foundation and 1 more | Director | 14 Feb 2011 | 15 Years 8 Months | Current |
| Vinutha Mandula Also directs: Sarama Trading LLP | Director | 10 Oct 2014 | 12 Years 0 Months | Current |
Peer comparison
Relixir Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| J M Healthcare Private Limited | ₹41.39 Cr (FY 2024) | 29.0% | Chandigarh, India | |||
| Curium Pharma (India) Private Limited | ₹41.38 Cr (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Vinuthana Chem Tech Private Limited | ₹41.25 Cr (FY 2025) | 6.0% | Hyderabad, Telangana, India | |||
| Stuck Chemicals Private Limited | ₹41.23 Cr (FY 2024) | 9.0% | New Delhi, Delhi, India | |||
| Relixir Pharmaceuticals Private Limitedthis company | ₹41.19 Cr (FY 2023) | -₹5.79 Cr | -14% | 48.0% | 60 | Hyderabad, Telangana, India |
| Lenus Life Care Private Limited | ₹41.1 Cr (FY 2024) | -30.0% | Chamba Ghar, Himachal Pradesh, India | |||
| Amishi Drugs and Chemicals Private Limited | ₹41.08 Cr (FY 2025) | 18.0% | Ahmedabad, Gujarat, India | |||
| Macrotech Polychem Private Limited | ₹40.96 Cr (FY 2025) | 46.0% | Mumbai, Maharashtra, India | |||
| Ruby Biopharma Private Limited | ₹40.92 Cr (FY 2025) | 24.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Relixir Pharmaceuticals Private Limited, buy the company report.
Auditor
Relixir Pharmaceuticals Private Limited is audited by GORANTLA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GORANTLA & CO | FY 2022 | 016943S |
Shareholding
The shareholding of Relixir Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Relixir Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹26.81 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2022 | 100581030 | Others | ₹1.45 Cr | Satisfied | |
| 23 Nov 2020 | 100394867 | Others | ₹70 Lakh | Satisfied | |
| 16 Aug 2017 | 100131752 | Others | ₹24.66 Cr | Satisfied |
To see the full charge records of Relixir Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Relixir Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Court case (STC - NI) | Filed against the company by an individual | Disposed |
To see the full case history of Relixir Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Relixir Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Relixir Pharmaceuticals Private Limited has a workforce of 60 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
60
Active EPFO establishments
1
Employee growth
-3.23%
GST
Relixir Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCR3136H1ZF | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Relixir Pharmaceuticals Private Limited, buy the company report.
Recent activity
Relixir Pharmaceuticals Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Nischal Yachamaneni ceased to be Director on 22 Oct 2019.
AGM
Relixir Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Relixir Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Charges
A charge registered on 30 Apr 2022 via Charge ID 100581030 with Others was fully satisfied on 23 Mar 2023.
Charges
A charge registered on 23 Nov 2020 via Charge ID 100394867 with Others was fully satisfied on 23 Mar 2023.
Charges
A charge registered on 16 Aug 2017 via Charge ID 100131752 with Others was fully satisfied on 23 Mar 2023.
Charges
A charge with Others amounted to Rs. 1.45 Cr with Charge ID 100581030 was registered on 30 Apr 2022.
Charges
A charge with Others of Rs. 24.66 Cr registered on 16 Aug 2017 with Charge ID 100131752 was modified on 21 Mar 2022.
Charges
A charge with Others amounted to Rs. 0.70 Cr with Charge ID 100394867 was registered on 23 Nov 2020.
Ceased
Nischal Yachamaneni ceased to be Director.
Charges
A charge with Others amounted to Rs. 24.66 Cr with Charge ID 100131752 was registered on 16 Aug 2017.
Ceased
Thirupathi Reddy Lakkireddy ceased to be Director.
Appointed
Vinutha Mandula was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Relixir Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 February 2011 (15+ years old) and is registered under CIN U24100TG2011PTC072584.
Relixir Pharmaceuticals has 2 current directors:
- Anil Kumar Devanapalli Ramaya - Director
- Vinutha Mandula - Director
The latest financial statements of Relixir Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Relixir Pharmaceuticals is 36AAGCR3136H1ZF, registered in Telangana.
The CIN (Corporate Identification Number) of Relixir Pharmaceuticals is U24100TG2011PTC072584. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Relixir Pharmaceuticals has 1 court case on record: 1 filed against it.
Relixir Pharmaceuticals was incorporated on 14 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Relixir Pharmaceuticals by revenue are J M Healthcare Private Limited, Curium Pharma (India) Private Limited, Vinuthana Chem Tech Private Limited, Stuck Chemicals Private Limited, Lenus Life Care Private Limited and 3 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nischal Yachamaneni ceased to be Director on 22 Oct 2019. Thirupathi Reddy Lakkireddy ceased to be Director on 22 Dec 2016. Vinutha Mandula was appointed as Director on 10 Oct 2014. Relixir Pharmaceuticals has 4 board changes on record in total.
Yes, Relixir Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0010265).
Relixir Pharmaceuticals can be reached through the website relixirpharma.com. Its registered office is in Hyderabad, Telangana, India.